Evaluation of HPV16 E7 expression in head and neck carcinoma cell lines and clinical specimens
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Evaluation of HPV16 E7 expression in head and neck carcinoma cell lines and clinical specimens ; volume:10 ; number:1 ; day:17 ; month:12 ; year:2020 ; pages:1-12 ; date:12.2020
Scientific reports ; 10, Heft 1 (17.12.2020), 1-12, 12.2020
- Urheber
-
Kitamura, Koji
Nimura, Keisuke
Ito, Rie
Saga, Kotaro
Inohara, Hidenori
Kaneda, Yasufumi
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-020-78345-8
- URN
-
urn:nbn:de:101:1-2021011819041279480988
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kitamura, Koji
- Nimura, Keisuke
- Ito, Rie
- Saga, Kotaro
- Inohara, Hidenori
- Kaneda, Yasufumi
- SpringerLink (Online service)
Ähnliche Objekte (12)
HPV16 mutant E6/E7 construct is protective in mouse model
MPS1 is involved in the HPV16-E7-mediated centrosomes amplification
Modulation der Immunogenität von HPV16-, L1-E7-chimären Virus-ähnlichen Partikeln
Preclinical investigation of DNA immunization with a rearranged human papillomavirus type 16 (HPV16) E7 oncogene
Exploring the roles of HPV16 variants in head and neck squamous cell carcinoma: current challenges and opportunities
Hypoxia inducible factor-1 alpha expression is increased in infected positive HPV16 DNA oral squamous cell carcinoma and positively associated with HPV16 E7 oncoprotein
Association of cervical carcinogenesis risk with HPV16 E6 and E7 variants in the Taizhou area, China
Enhancing antitumor immunogenicity of HPV16-E7 DNA vaccine by fusing DNA encoding E7-antigenic peptide to DNA encoding capsid protein L1 of Bovine papillomavirus
Human papillomavirus-encoded circular RNA circE7 promotes immune evasion in head and neck squamous cell carcinoma
Local radiotherapy and E7 RNA-LPX vaccination show enhanced therapeutic efficacy in preclinical models of HPV16+ cancer
Local radiotherapy and E7 RNA-LPX vaccination show enhanced therapeutic efficacy in preclinical models of HPV16+ cancer
A naturally processed and HLA-B8 presented HPV16 E7 epitope recognized by T-cells from patients with cervical cancer : = Ein natürlich prozessiertes und HLA-B8-präsentiertes Epitop des Onkogens HPV16 E7 wird durch T-Zellen von Zervixkarzinompatientinnen erkannt
HPV16 mutant E6/E7 construct is protective in mouse model
MPS1 is involved in the HPV16-E7-mediated centrosomes amplification
Modulation der Immunogenität von HPV16-, L1-E7-chimären Virus-ähnlichen Partikeln
Preclinical investigation of DNA immunization with a rearranged human papillomavirus type 16 (HPV16) E7 oncogene
Exploring the roles of HPV16 variants in head and neck squamous cell carcinoma: current challenges and opportunities
Hypoxia inducible factor-1 alpha expression is increased in infected positive HPV16 DNA oral squamous cell carcinoma and positively associated with HPV16 E7 oncoprotein
Association of cervical carcinogenesis risk with HPV16 E6 and E7 variants in the Taizhou area, China
Enhancing antitumor immunogenicity of HPV16-E7 DNA vaccine by fusing DNA encoding E7-antigenic peptide to DNA encoding capsid protein L1 of Bovine papillomavirus
Human papillomavirus-encoded circular RNA circE7 promotes immune evasion in head and neck squamous cell carcinoma
Local radiotherapy and E7 RNA-LPX vaccination show enhanced therapeutic efficacy in preclinical models of HPV16+ cancer
Local radiotherapy and E7 RNA-LPX vaccination show enhanced therapeutic efficacy in preclinical models of HPV16+ cancer
A naturally processed and HLA-B8 presented HPV16 E7 epitope recognized by T-cells from patients with cervical cancer : = Ein natürlich prozessiertes und HLA-B8-präsentiertes Epitop des Onkogens HPV16 E7 wird durch T-Zellen von Zervixkarzinompatientinnen erkannt
HPV16 mutant E6/E7 construct is protective in mouse model
MPS1 is involved in the HPV16-E7-mediated centrosomes amplification
Modulation der Immunogenität von HPV16-, L1-E7-chimären Virus-ähnlichen Partikeln
Preclinical investigation of DNA immunization with a rearranged human papillomavirus type 16 (HPV16) E7 oncogene
Exploring the roles of HPV16 variants in head and neck squamous cell carcinoma: current challenges and opportunities
Hypoxia inducible factor-1 alpha expression is increased in infected positive HPV16 DNA oral squamous cell carcinoma and positively associated with HPV16 E7 oncoprotein
Association of cervical carcinogenesis risk with HPV16 E6 and E7 variants in the Taizhou area, China
Enhancing antitumor immunogenicity of HPV16-E7 DNA vaccine by fusing DNA encoding E7-antigenic peptide to DNA encoding capsid protein L1 of Bovine papillomavirus
Human papillomavirus-encoded circular RNA circE7 promotes immune evasion in head and neck squamous cell carcinoma
Local radiotherapy and E7 RNA-LPX vaccination show enhanced therapeutic efficacy in preclinical models of HPV16+ cancer
Local radiotherapy and E7 RNA-LPX vaccination show enhanced therapeutic efficacy in preclinical models of HPV16+ cancer